Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radioprotection combined with hypoxic sensitization during radiotherapy of a solid; murine tumor

Journal Article · · Radiology; (United States)

EMT6 tumors were transplanted intramuscularly in the right hind leg of female BALC/c mice and irradiated when they reached a diameter of 6 to 7 mm. Each mouse received an intraperitoneal injection of WR-2721, misonidazole, or both prior to irradiation, and the dose needed to control half of the tumors at 30 days (TCD/sub 50/30/) was recorded. WR-2721 offered slight tumor protection, with a dose-modifying factor (DMF) of 1.04 to 1.15 for radioprotector doses of 150 to 500 mg/kg. Pretreatment with misonidazole at doses of 300 to 900 mg/kg yielded tumor sensitization with a DMF of 0.71 to 0.92. Pretreatment with both WR-2721 and misonidazole gave overall tumor sensitization with a DMF of 0.78 to 0.97. Possible combinations of sensitizers and protectors, while providing overall tumor sensitization, do not seem to improve the therapeutic ratio over what could be obtained from a sensitizer or protector along.

Research Organization:
Univ. of Kentucky, Lexington
OSTI ID:
5815879
Journal Information:
Radiology; (United States), Journal Name: Radiology; (United States) Vol. 148:1; ISSN RADLA
Country of Publication:
United States
Language:
English